학술논문
HIV treatment with dolutegravir and doravirine: rationale for selection and clinical outcomes in a highly treatment experienced population.
Document Type
Article
Source
International Journal of STD & AIDS; Oct2022, Vol. 33 Issue 12, p1073-1077, 5p
Subject
Language
ISSN
09564624